Oncogenic miR-9 is a target of erlotinib in NSCLCs

EGFR-targeted cancer therapy is a breakthrough in non-small cell carcinoma. miRNAs have been proved to play important roles in cancer. Currently, for the role of miRNAs in EGFR-targeted cancer therapy is unclear. In this study, first we found that erlotinib reduced the expression of miR-9. MiR-9 exp...

Full description

Saved in:
Bibliographic Details
Published in:Sci Rep
Main Authors: Chen, Xi, Zhu, Lingjun, Ma, Zhuo, Sun, Geng, Luo, Xuan, Li, Min, Zhai, Sulan, Li, Ping, Wang, Xuerong
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4655475/
https://ncbi.nlm.nih.gov/pubmed/26593208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep17031
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items